Community-associated MRSA (CA-MRSA): An emerging pathogen in infective endocarditis

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 1-7

  Millar, B Cherie ^a   Prendergast, Bernard D ^b   Moore, John E ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Community acquired MRSA; Panton Valentine leucocidin; PVL

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; MINOCYCLINE; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL TRANSMISSION; COMMUNICABLE DISEASE; DIABETES MELLITUS; DRUG DOSE TITRATION; HEART VALVE REPLACEMENT; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VAGOTOMY;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS; GUIDELINES AS TOPIC; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 37549045236     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm410     Document Type: Article

References (23)

1. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-poskive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600.
2. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
3. Tsuji BT, Rybak MJ, Cheung CM et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: A comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis 2007; 58: 41-7.
4. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: Current perspectives. Clin Microbiol Infect 2006; 12 Suppl 1: 9-15.
5. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylocoocus aureus disease? J infect Dis 2006; 194: 1761-70.
6. Millar BC, Loughrey A, Elbom JS et al. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007; 67: 109-13.
7. Zetola N, Francis JS, Nuermberger EL et al. Community-acquired methicillin-resistant Staphylocoocus aureus: An emerging threat. Lancet Infect Dis 2005; 5: 275-86.
8. Bahrain M, Vasiliades M, Wolff M et al. Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 2006; 38: 702-7.
9. Hsu LY, Koh TH, Tan TY et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus in Singapore: A further six cases. Singapore Med J 2006; 47: 20-6.
10. Crum NF. The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 2005; 37: 651-6.
11. Healy CM, Hulten KG, Palazzi DL et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39: 1460-6.
12. Haque NZ, Davis SL, Manierski CL et al. Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30: 72-7.
13. Tsigrelis C, Armstrong MD, Vlahakis NE et al. Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains. Scand J Infect Dis 2007; 39: 299-302.
14. Murray RJ, Lim TT, Pearson JC et al. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int J Infect Dis 2004; 8: 275-83.
15. Pefanis A, Kasiakou S, Papaetis et al. Endocarditis and spondylitis due to community-acquired methicillin-resistant Staphylococcus aureus, (CA-MRSA) - a case report. In: Abstracts of the Ninth International Symposium of Modem Concepts in Endocarditis and Cardiovascular Infections, 2007. Clin Res Cardiol 96: 406.
16. Lin JC, Wu JS, Chang FY. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis with septic embolism of popliteal artery: A case report. J Microbiol Immunol Infect 2000; 33: 57-9.
17. Pistella E, Campanile F, Bongiomo D et al. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylocoocus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand J Infect Dis 2004; 36: 222-5.
18. Miro JM, Anguera I, Cabell CH et al. Staphylococcus aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005; 41: 507-14.
19. Lalani T, Person AK, Hedayati SS et al. Propionibacterium endocarditis: A case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study. Scand J Infect Dis 2007; in press.
20. Benjamin DK, Jr, Miro JM, Hoen B et al. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD). Scand J Infect Dis 2004; 36: 453-5.
21. Elliott TS, Foweraker J, Gould FK et al. Guidelines for the antibiotic treatment of endocarditis in adults: Report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54: 971-81.
22. Horstkotte D, Follath F, Gutschik E et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25: 267-76.
23. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: E394-434.